Progression Patterns of Choroidal Venous Alterations (CVA)
International Multi-centre, Prospective, Longitudinal Cohort to Evaluate the Progression Pattern of Choroidal Venous Alterations
Study Overview
Status
Status
Conditions
Conditions
Detailed Description
Study Type
Study Type
Enrollment (Estimated)
Enrollment
Contacts and Locations
Study Contact
Study Contact
- Name: Gemmy Cheung
- Phone Number: +65 63227460
- Email: gemmy.cheung.c.m@singhealth.com.sg
Study Locations
-
-
-
Hong Kong, Hong Kong
- Recruiting
- Hong Kong University
-
Contact:
- Angie Fong
- Phone Number: 852 2518 1430
- Email: fongahc@hku.hk
-
-
-
-
-
Kuala Lumpur, Malaysia
- Recruiting
- University of Malaya Medical Centre
-
Contact:
- Lott Pooi Wah Dr
- Phone Number: 03-79677022
- Email: lottpw@um.edu.my
-
-
-
-
-
Singapore, Singapore
- Recruiting
- National University Hospital, Singapore
-
Contact:
- Wendy Wong
- Phone Number: +65
- Email: wendy_wong@nuhs.edu.sg
-
Singapore, Singapore
- Recruiting
- Singapore National Eye Centre/ Singapore Eye Research Institute
-
Contact:
- Gemmy Cheung
- Phone Number: +65 63227460
- Email: gemmy.cheung.c.m@singhealth.com.sg
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Sampling Method
Study Population
Description
Inclusion Criteria:
- Adults aged 45 years or older.
- Presence of pachyvessels on ultra-widefield (UWF) imaging in at least one quadrant.
- Willing to undergo pupil dilation, and protocol-required procedures for both eyes
- Willing to provide written informed consent
Exclusion Criteria:
- Presence of disorders of the ocular media which interfere with visual acuity and other ocular assessments during the study period
- Eyes with other ocular pathology such as trauma, inflammation, previous intraocular surgery (except for cataract surgery)
- Systemic diseases that might affect ocular blood flow such as uncontrolled hypertension, autoimmune disease, and haematological disorders
- Pregnant or nursing women
- Persons who are unable to give informed consent
Study Plan
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Progression of choroidal venous alterations
Time Frame: 3 years
|
Proportion of eyes demonstrating progression of choroidal venous alterations, defined as either an increase in number of quadrants with pachyvessels or formation of new choroidal anastomoses.
|
3 years
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Incidence of progression of pachychoroid disease manifestation
Time Frame: 3 years
|
New onset of Central Serous Chorioretinopathy (CSCR), focal Retinal Pigment Epithelium (RPE) changes, or other pachychorois related findings.
|
3 years
|
|
Risk factors associated with progression of choroidal venous alteration
Time Frame: 3 years
|
Assessment of demographic, cilinical, and imaging parameters associated with progression.
|
3 years
|
Collaborators and Investigators
Sponsor
Sponsor
Collaborators
Collaborators
Study record dates
Study Major Dates
Study Start (Actual)
Study Start
Primary Completion (Estimated)
Primary Completion
Study Completion (Estimated)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Other Study ID Numbers
Other Study ID Numbers
- 2024-4359
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.